VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023 03; 29(3):593-604.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Humans
Ipilimumab
Lung Neoplasms
Melanoma
Neoadjuvant Therapy
authors with profiles
WAYNE L HOFSTETTER
BONNIE S GLISSON
JAMES P ALLISON
REZA JOHN MEHRAN
IGNACIO IVAN WISTUBA
DON LYNN GIBBONS
APAR PATAER
MARA B ANTONOFF
JOHN VICTOR HEYMACH
MYRNA GODOY
GARRETT L WALSH
CARA L HAYMAKER
ANNIKKA WEISSFERDT
LAUREN AVERETT BYERS
BRETT CARTER
JUNYA FUJIMOTO
STEPHEN G SWISHER
PADMANEE SHARMA
ANNE TSAO
FRANK V FOSSELLA
JENNIFER WARGO
FERDINANDOS SKOULIDIS
BORIS SEPESI
DAVID C RICE
GEORGE R BLUMENSCHEIN
ARA A VAPORCIYAN